These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32520788)

  • 61. Radium-223 chloride: Extending life in prostate cancer patients by treating bone metastases.
    Wissing MD; van Leeuwen FW; van der Pluijm G; Gelderblom H
    Clin Cancer Res; 2013 Nov; 19(21):5822-7. PubMed ID: 24052017
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases.
    Uemura H; Uemura H; Nagamori S; Wakumoto Y; Kimura G; Kikukawa H; Yokomizo A; Mizokami A; Kosaka T; Masumori N; Kawasaki Y; Yonese J; Nasu Y; Fukasawa S; Sugiyama T; Kinuya S; Hosono M; Yamaguchi I; Akagawa T; Matsubara N
    Int J Clin Oncol; 2019 May; 24(5):557-566. PubMed ID: 30875000
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Bone-specific therapy with radium-223 dichloride : Castration-resistant prostate cancer with symptomatic bone metastases].
    Tauber R; Gschwend J; Scheidhauer K; Eiber M; Krönke M
    Urologe A; 2017 Jan; 56(1):24-31. PubMed ID: 28058455
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of pre-treatment variables on the completion of
    Lavelli V; Nappi AG; Caputo P; Asabella AN; Fanelli M; Sardaro A; Altini C; Ferrari C; Rubini G
    Hell J Nucl Med; 2019; 22 Suppl 2():153-163. PubMed ID: 31802056
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dosing, administration, and safety of radium-223: How I do it.
    Dan TD; Doyle L; Raval AJ; Pridjian A; Gomella LG; Den RB
    Can J Urol; 2016 Jun; 23(3):8301-5. PubMed ID: 27347625
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The American College of Radiology and the American Brachytherapy Society practice parameter for transperineal permanent brachytherapy of prostate cancer.
    Bittner NH; Orio PF; Merrick GS; Prestidge BR; Hartford AC; Rosenthal SA
    Brachytherapy; 2017; 16(1):59-67. PubMed ID: 28109632
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Alpha-emitter radium-223 in the management of solid tumors: current status and future directions.
    Nilsson S
    Am Soc Clin Oncol Educ Book; 2014; ():e132-9. PubMed ID: 24857093
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Clinical Efficacy of Radium-223 for Bone Metastasis in Patients with Castration-Resistant Prostate Cancer: An Italian Clinical Experience.
    De Luca R; Costa RP; Tripoli V; Murabito A; Cicero G
    Oncology; 2018; 94(3):161-166. PubMed ID: 29241166
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Radium-223 dichloride for the treatment of bone metastatic castration-resistant prostate cancer: an evaluation of its safety.
    Nilsson S
    Expert Opin Drug Saf; 2015 Jul; 14(7):1127-36. PubMed ID: 26022669
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Radium-223 treatment of bone metastases from castration-resistant prostate cancer].
    Mortensen J; Højgaard L
    Ugeskr Laeger; 2014 Jul; 176(30):1399-402. PubMed ID: 25292232
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Radium-223 dichloride for the treatment of metastatic prostate cancer.
    Turner PG; O'Sullivan J
    Expert Opin Pharmacother; 2014 Oct; 15(14):2105-11. PubMed ID: 25186336
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Radiometabolic treatment of bone-metastasizing cancer: from 186rhenium to 223radium.
    Rubini G; Nicoletti A; Rubini D; Asabella AN
    Cancer Biother Radiopharm; 2014 Feb; 29(1):1-11. PubMed ID: 24180669
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Metastatic Prostate Cancer and the Bone: Significance and Therapeutic Options.
    Gartrell BA; Coleman R; Efstathiou E; Fizazi K; Logothetis CJ; Smith MR; Sonpavde G; Sartor O; Saad F
    Eur Urol; 2015 Nov; 68(5):850-8. PubMed ID: 26153564
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS).
    Hasan H; Deek MP; Phillips R; Hobbs RF; Malek R; Radwan N; Kiess AP; Dipasquale S; Huang J; Caldwell T; Leitzel J; Wendler D; Wang H; Thompson E; Powell J; Dudley S; Deville C; Greco SC; Song DY; DeWeese TL; Gorin MA; Rowe SP; Denmeade S; Markowski M; Antonarakis ES; Carducci MA; Eisenberger MA; Pomper MG; Pienta KJ; Paller CJ; Tran PT
    BMC Cancer; 2020 Jun; 20(1):492. PubMed ID: 32487038
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bone-seeking radiopharmaceuticals as targeted agents of osteosarcoma: samarium-153-EDTMP and radium-223.
    Anderson PM; Subbiah V; Rohren E
    Adv Exp Med Biol; 2014; 804():291-304. PubMed ID: 24924181
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment of Metastatic Bone Disease and the Emerging Role of Radium-223.
    Coleman R
    Semin Nucl Med; 2016 Mar; 46(2):99-104. PubMed ID: 26897713
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Radionuclide therapy for the treatment of skeletal metastases of urological malignancies: a forgotten therapy?].
    Badawi JK
    Dtsch Med Wochenschr; 2012 Aug; 137(33):1645-9. PubMed ID: 22875692
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Nuclear medicine in oncotherapy].
    Pávics L; Besenyi Z
    Magy Onkol; 2015 Sep; 59(3):193-7. PubMed ID: 26339908
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Management of bone metastases in prostate cancer: a review.
    Bienz M; Saad F
    Curr Opin Support Palliat Care; 2015 Sep; 9(3):261-7. PubMed ID: 26262831
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial.
    Hoskin P; Sartor O; O'Sullivan JM; Johannessen DC; Helle SI; Logue J; Bottomley D; Nilsson S; Vogelzang NJ; Fang F; Wahba M; Aksnes AK; Parker C
    Lancet Oncol; 2014 Nov; 15(12):1397-406. PubMed ID: 25439694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.